q2-emperor 2022.2.0-1 source package in Ubuntu

Changelog

q2-emperor (2022.2.0-1) unstable; urgency=medium

  * New upstream version

 -- Steffen Moeller <email address hidden>  Tue, 12 Jul 2022 13:01:59 +0200

Upload details

Uploaded by:
Debian Med
Uploaded to:
Sid
Original maintainer:
Debian Med
Architectures:
all
Section:
misc
Urgency:
Medium Urgency

See full publishing history Publishing

Series Pocket Published Component Section

Builds

Kinetic: [FULLYBUILT] amd64

Downloads

File Size SHA-256 Checksum
q2-emperor_2022.2.0-1.dsc 2.2 KiB 6b39927bb5ae4b8a820048c3e283510102f59ba2b1cf4f224e68c566fd018fb0
q2-emperor_2022.2.0.orig.tar.gz 238.2 KiB d66345d06e6fceb2ff98e917d28ab70fcffe7d32511f0d5a7753f446f6a7923b
q2-emperor_2022.2.0-1.debian.tar.xz 7.6 KiB 382b22300890326f432deefb7d8d29c6463713da9fc858c9e7575514fe80f837

Available diffs

No changes file available.

Binary packages built by this source

q2-emperor: QIIME2 plugin for display of ordination plots

 QIIME 2 is a powerful, extensible, and decentralized microbiome analysis
 package with a focus on data and analysis transparency. QIIME 2 enables
 researchers to start an analysis with raw DNA sequence data and finish with
 publication-quality figures and statistical results.
 Key features:
  * Integrated and automatic tracking of data provenance
  * Semantic type system
  * Plugin system for extending microbiome analysis functionality
  * Support for multiple types of user interfaces (e.g. API, command line,
 graphical)
 .
 QIIME 2 is a complete redesign and rewrite of the QIIME 1 microbiome analysis
 pipeline. QIIME 2 will address many of the limitations of QIIME 1, while
 retaining the features that makes QIIME 1 a powerful and widely-used analysis
 pipeline.
 .
 QIIME 2 currently supports an initial end-to-end microbiome analysis pipeline.
 New functionality will regularly become available through QIIME 2 plugins. You
 can view a list of plugins that are currently available on the QIIME 2 plugin
 availability page. The future plugins page lists plugins that are being
 developed.